Yakult Honsha Co.,Ltd.
2267
Peringkat dalam Saham
#3385
Yakult Honsha Co.,Ltd. is a diversified Japanese enterprise engaged in the... Yakult Honsha Co.,Ltd. is a diversified Japanese enterprise engaged in the manufacturing and sale of a broad array of products, including food and beverages, cosmetics, and pharmaceuticals. The company's operations are segmented geographically for its Food and Beverages division, covering Japan, the Americas, Asia and Oceania, and Europe, alongside dedicated Pharmaceutical and "Others" segments. Its extensive food and beverage offerings feature popular items such as fermented milk beverages, various juices, and noodle products, which are distributed through both a home delivery service and traditional retail channels. In the pharmaceutical sector, Yakult Honsha provides specific medications like the antineoplastic drug Elplat, along with a suite of generic anti-cancer treatments, including Gemcitabine Yakult, Capecitabine, and Gefitinib Yakult tablets. Furthermore, the company maintains a presence in the cosmetics industry and is notably the owner of the professional baseball team, the Tokyo Yakult Swallows. Founded in 1935, Yakult Honsha Co.,Ltd. is headquartered in Tokyo, Japan.
Harga Saham
$17.80
Kapitalisasi Pasar
$5.12B
Perubahan (1 hari)
-0.04%
Perubahan (1 tahun)
11.52%
Negara
JP
Perdagangan Yakult Honsha Co.,Ltd. (2267)
Kategori
Consumer Defensive
Laba untuk Yakult Honsha Co.,Ltd. (2267)
Laba pada 2026 TTM: 0
Menurut laporan keuangan terbaru dari Yakult Honsha Co.,Ltd., laba saat ini perusahaan adalah 0. Pada tahun 2026, perusahaan memperoleh laba sebesar 0, sama dengan laba tahun 2026 sebesar 0. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk Yakult Honsha Co.,Ltd. dari 2026 hingga 2026
Laba pada akhir setiap tahun
| Tahun | Laba | Mengubah |
|---|---|---|
| Tidak cukup data untuk tanggal yang disediakan. | ||
Laba untuk perusahaan serupa atau pesaing
| Perusahaan | Laba | Perbedaan Laba | Negara |
|---|---|---|---|
| $17.23B | - |
US
|
|
| $13.73B | - |
US
|
|
| $2.78B | - |
US
|
|
| $3.25B | - |
CN
|
|
| $1.97B | - |
US
|
